Logo-hpp
2023: Two-year Impact Factor: 2.4
Scopus Journal Metrics
CiteScore (2023):7.1
  		Platinum
Open Access
Health Promot Perspect. 2024;14(4): 380-387. doi: 10.34172/hpp.42486

Original Article

The effects of empagliflozin in patients with type 1 diabetes: Results of a 12-week, double-blind, randomized, placebo-controlled clinical trial

Mostafa Najafipour 1 ORCID, Farzad Najafipour 2 * ORCID, Alireza Ostadrahimi 3, Maryam Ghavami 1, Zohreh Razaghi 2, Helda Tutunchi 2, Naimeh Mesri Alamdari 2 * ORCID

Cited by CrossRef:


Indexing and Abstracting

2-year Impact Factor: 2.4

SCOPUS CiteScore: 7.1

  Scimago Journal & Country Rank 

 


     Linked in Profile

   Academia Profile

Officially associated with The Iranian Health Education & Promotion Association  
Publication Advantages

Free of charge publication

Open access 

Fast and constructive peer review

Easy and fast online submission